Every Form 4 that Omega Healthcare (OHI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OHI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OHI filings page.
Omega Healthcare Investors Inc. director Lisa Egbuonu-Davis reported a bona fide gift of 5,131 shares of Common Stock on 2026-08-07. The transaction was recorded at a price of $0.00 per share, and her directly held position after the gift is 17,301 shares.
Omega Healthcare Investors' chief financial officer Robert O. Stephenson reported compensation-related equity activity involving partnership and profits interest units. On June 30, 2026, he exercised or converted derivative awards covering a total of 79,298 units, including OP Units that are exchangeable into common stock and Profits Interest Units that convert into OP Units. The transactions were recorded at an exercise price of $0.00 per unit, reflecting incentive awards rather than open-market purchases. Following these conversions, he directly holds 758,743 shares of common stock and continues to hold OP Units and Profits Interest Units, which are tied to performance measures such as Absolute and Relative Total Shareholder Return for the 2023–2025 period.
Omega Healthcare Investors CEO C. Taylor Pickett reported equity incentive vesting and derivative exercises involving partnership units linked to the company’s common stock. On June 30, 2026, he exercised a total of 190,806 Profits Interest Units and OP Units at an exercise price of $0.00 per unit, converting them into higher-tier OP Units and common stock-based interests.
Following these transactions, direct holdings included 1,320,406 OP Units in one line and 1,294,229 OP Units in another, plus 405,345 Profits Interest Units, all tied economically to Omega’s common stock under the partnership agreement. Separately, 112,500 OP Units are held in an irrevocable trust for his spouse and son, over which he has no voting power; this trust position did not change and continues to be reported for beneficial ownership.
Omega Healthcare Investors chief legal officer Gail D. Makode reported compensation-related equity activity. On June 30, 2026, she exercised derivative awards covering a total of 40,964 units, including Profits Interest Units and OP Units, at an exercise price of $0.00 per unit.
Footnotes explain that each Profits Interest Unit can vest into one OP Unit of the operating partnership, and each OP Unit is redeemable for cash equal to the fair market value of one share of Omega common stock, or, at the company’s election, one share of common stock. The vested portions reflect 25% tranches tied to absolute and relative total shareholder return performance for the 2023–2025 period, with vesting spread across calendar quarters in 2026 and subject to continued employment. The filing shows no open‑market sales or gifts.
OMEGA HEALTHCARE INVESTORS INC Chief Investment Officer Vikas Gupta reported derivative exercises tied to long-term incentive awards. On these transactions, he exercised or converted a total of 40,964 units linked to the company’s equity, including OP Units and Profits Interest Units (PIUs).
The PIUs are performance-based awards in OHI Healthcare Properties Limited Partnership that vest into OP Units based on Absolute and Relative Total Shareholder Return for the 2023-2025 period, subject to continued employment. Each OP Unit can later be redeemed for cash equal to the fair market value of one share of Omega common stock, or, at Omega’s election, for one share of common stock. No open-market buys or sales were reported in this filing.
OMEGA HEALTHCARE INVESTORS INC President Matthew Paul Gourmand exercised performance-based equity awards into partnership interests on June 30, 2026. He converted a total of 40,964 Profits Interest Units and OP Units through derivative exercises linked to the company’s 2023–2025 Absolute and Relative Total Shareholder Return performance, with no share sales reported in this filing.
Omega Healthcare Investors' chief accounting officer Neal Ballew reported routine equity compensation activity and an employee share purchase. He acquired 168 shares of common stock at $37.25 per share through the company’s Employee Stock Purchase Plan, while 11 shares at $47.68 were surrendered to the issuer to cover tax withholding obligations related to that purchase. Following these transactions, he directly holds 4,676 common shares.
On June 30, 2026, Ballew also exercised equity-based awards. A total of 40,964 Profits Interest Units vested and converted into Operating Partnership units and then into common stock, tied to absolute and relative total shareholder return performance for the 2023–2025 period. After these conversions, he continues to hold 168,804 OP Units and 89,333 Profits Interest Units, reflecting substantial remaining equity exposure.
Omega Healthcare Investors director Burke W. Whitman received an equity grant of 3,778 shares of common stock as director compensation. The award was valued at $43.67 per share on the grant date of June 5, 2026 and was made under a Restricted Stock Grant Award Agreement.
The shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, about one year after the grant, and will then convert to common stock on a one-for-one basis. After this award, Whitman directly holds a total of 47,931 common shares.
Omega Healthcare Investors director Stephen D. Plavin reported equity-based compensation and a derivative conversion. On June 5, 2026, he received a grant of 3,814 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership at a price of $0.00 per unit.
All 4,424 of his previously granted PIUs from June 6, 2025 vested and converted into 4,424 OP Units on the same date. Following the conversion, he directly holds 23,215 OP Units. Each OP Unit can be redeemed for cash equal to the fair market value of one share of Omega Healthcare common stock, or, at the company’s election, one share of common stock. The new 2026 PIUs will vest in full on the date of the company’s 2027 Annual Meeting of Shareholders, subject to continued service.
Omega Healthcare Investors director Kevin J. Jacobs received an equity grant of 6,125 shares of Common Stock as director compensation. The award was granted on June 5, 2026 under a Restricted Stock Grant Award Agreement at a reference price of $43.67 per share.
According to the terms, the restricted shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis. After this grant, Jacobs directly holds 46,935 shares of Omega Healthcare Investors common stock.
Omega Healthcare Investors director Barbara B. Hill reported equity-based compensation and conversions. She received a grant of 6,102 Profits Interest Units (PIUs) in the company’s operating partnership as annual stock-based compensation. Separately, 7,079 previously granted PIUs fully vested and converted into OP Units, which are partnership interests redeemable for cash equal to the value of one common share or, at the company’s election, one share of common stock. Following these transactions, Hill directly holds 49,073 OP Units in the operating partnership.
Omega Healthcare Investors director Lisa Egbuonu-Davis received a grant of 3,778 shares of common stock as director compensation on June 5, 2026. The award was made via a Restricted Stock Grant Award Agreement at an indicated value of $43.67 per share.
The restricted shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis. Following this compensation grant, Egbuonu-Davis directly holds 22,432 shares of Omega Healthcare Investors common stock.
OMEGA HEALTHCARE INVESTORS INC director Anand Kapila K received an equity award in the form of deferred stock units. On the reported date, he was granted 6,205 Deferred Stock Units at no cash cost as an annual restricted stock grant elected to be taken in this form.
Each unit converts into one share of common stock, and related dividends can also be credited as additional units if elected. The units are restricted from transfer or sale until Omega's 2027 Annual Meeting of Shareholders, defined as the vesting date, and will convert into common shares upon separation from service, death, disability, or other specified plan events. Following this grant, he holds 44,992 Deferred Stock Units directly.
OMEGA HEALTHCARE INVESTORS INC director Craig R. Callen reported equity-based compensation and related conversions, with only acquisition-type transactions and no share sales. He received a grant of 9,708 Profits Interest Units (PIUs) on June 5, 2026, representing a contingent right to receive an equal number of OP Units upon vesting and satisfaction of tax-driven economic requirements. On the same date, 11,263 previously granted PIUs vested and converted into 11,263 OP Units. A related transaction shows 11,263 OP Units exercised into common stock equivalents, leaving 74,310 OP Units held directly. The 2026 PIU grant is described as his annual stock grant and will fully vest on the date of the company’s 2027 Annual Meeting of Shareholders, subject to continued service.
PICKETT C TAYLOR reported open-market sale transactions in this Form 4 filing.
Omega Healthcare Investors CEO C. Taylor Pickett reported a redemption of 112,500 OP Units for cash. According to the filing, each OP Unit of OHI Healthcare Properties Limited Partnership was redeemed at $47.94, equal to the 10-day average closing price of the company’s common stock before the redemption notice.
Each OP Unit is redeemable, at the holder’s election, for cash equal to the fair market value of one share of common stock or, at the company’s election, one share of common stock and has no expiration date. After these transactions, Pickett also has OP Units representing an underlying 1,225,003 shares of common stock held directly.
Omega Healthcare Investors’ chief legal officer, Gail D. Makode, exercised partnership-based equity awards tied to the company’s performance. On March 31, 2026, she converted a total of 40,966 Profits Interest Units into OP Units in the operating partnership and related OP Units into interests linked to common stock value.
After these transactions, she directly holds 101,201 Profits Interest Units and 224,508 OP Units. Each OP Unit can be redeemed for cash equal to the fair market value of one Omega Healthcare common share, or, at the company’s election, one share of common stock. The vesting of these awards was based on Absolute and Relative Total Shareholder Return for the 2023–2025 performance period and required continued employment.
OMEGA HEALTHCARE INVESTORS INC Chief Investment Officer Vikas Gupta reported compensation-related equity vesting and derivative exercises. On March 31, 2026, he exercised awards covering 40,966 units at an exercise price of $0.00 per unit.
These transactions reflect Profits Interest Units that vested into OP Units, and OP Units that became redeemable for cash or one share of common stock, based on Absolute and Relative Total Shareholder Return for the 2023–2025 performance period. Following the exercises, Gupta directly holds 118,201 Profits Interest Units and 225,988 OP Units, indicating a substantial continuing equity stake. The activity appears tied to previously granted performance-based awards rather than open-market buying or selling.
Omega Healthcare Investors president Matthew Paul Gourmand reported compensation-related equity vesting and conversions. On March 31, 2026, he exercised Profits Interest Units (PIUs) into OP Units and then converted those OP Units into common stock at a $0.00 exercise price.
Two tranches of 14,863 and 5,620 PIUs vested into OP Units, and matching OP Unit amounts converted into the same number of common shares. The filing shows 211,876 shares of common stock held directly after these transactions. Footnotes explain the PIUs were earned based on absolute and relative total shareholder return for the 2023–2025 performance period, with 25% vesting each quarter in 2026, as certified by the Compensation Committee on January 8, 2026. No sales were reported.
Omega Healthcare Investors' chief financial officer Robert O. Stephenson exercised performance-based equity awards linked to the company’s operating partnership. On March 31, 2026, he converted a total of 79,298 Profits Interest Units into OP Units, and then into an equal number of OP Units tied to common stock, at a stated exercise price of $0.0000 per unit.
The awards were based on Absolute and Relative Total Shareholder Return for the 2023–2025 performance period and vested in 25% quarterly increments during 2026, subject to continued employment and possible accelerated vesting, as certified by the compensation committee on January 8, 2026. After these transactions, he directly holds 719,094 OP Units exchangeable into cash or Omega common shares at the issuer’s election, with no open derivative positions shown.
Omega Healthcare Investors CEO C. Taylor Pickett exercised performance-based equity awards linked to partnership units. On March 31, 2026, he exercised Profits Interest Units into 69,226 and 26,177 OP Units, then exercised those OP Units into an equal number of common shares at a $0.00 exercise price.
The filing shows derivative exercises covering a total of 190,806 units, including 95,403 OP Units that became common stock. These awards vested based on Absolute and Relative Total Shareholder Return for the 2023–2025 period, subject to continued employment. Following the transactions, he directly holds 1,225,003 shares of common stock.
Omega Healthcare Investors' chief accounting officer Neal Ballew reported routine equity compensation and related conversions. He acquired 168 shares of common stock at $37.25 per share through the Employee Stock Purchase Plan, with 8 shares returned to the company to cover tax withholding at $43.82 per share.
He also exercised 14,863 and 5,620 Profits Interest Units into the same number of OP Units, and then converted 14,863 and 5,620 OP Units into common stock. Following these transactions, he directly holds 4,508 common shares and 148,322 OP Units, which are redeemable for cash or common stock as described.
Omega Healthcare Investors’ chief accounting officer, Neal Ballew, received an award of 14,401 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership on January 13, 2026. Each PIU represents a contingent right to receive one limited partnership unit (an OP Unit) in the operating partnership once vesting and certain tax-related conditions are met.
The OP Units can be redeemed by the holder for cash equal to the fair market value of one share of Omega Healthcare common stock or, at the company’s election, one share of common stock, and they have no expiration date. The award is subject to a three-year cliff vesting on December 31, 2028, conditioned on continued employment with specified exceptions. After this grant, Ballew beneficially owns 124,678 derivative OP Units directly.
Omega Healthcare Investors' president Matthew Paul Gourmand reported a grant of 42,805 Profits Interest Units on 01/13/2026. These are derivative securities in OHI Healthcare Properties Limited Partnership, where Omega Healthcare Investors is the general partner, and were granted at a price of $0 per unit.
Each Profits Interest Unit represents a contingent right to receive one OP Unit upon vesting and meeting certain tax-driven economic requirements. Each OP Unit can be redeemed at the holder’s election for cash equal to the fair market value of one share of Omega Healthcare Investors common stock or, at the issuer’s election, one share of common stock. After this grant, Gourmand beneficially owns 160,767 derivative securities. The units are subject to a three-year vesting cliff on 12/31/2028, requiring continued employment through the vesting date, with certain exceptions for qualifying terminations, and the OP Units do not expire.
Omega Healthcare Investors filed a Form 4 showing that Chief Investment Officer Vikas Gupta received 18,898 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership on 01/13/2026 at a price of $0 per unit. Following this grant, he beneficially owns 133,064 PIUs. Each PIU represents a contingent right to receive one limited partnership unit (an OP Unit) upon vesting and satisfaction of certain tax-driven economic conditions. Each OP Unit is redeemable, at the holder’s election, for cash equal to the fair market value of one share of Omega Healthcare common stock or, at the issuer’s election, one share of common stock. The grant is subject to a three-year vesting cliff on 12/31/2028, conditioned on continued employment (with certain exceptions for qualifying termination), and the OP Units do not expire.
Omega Healthcare Investors’ chief legal officer, Gail D. Makode, reported an award of 11,407 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership on 01/13/2026 at a price of $0 per unit. Following this grant, she beneficially owns 121,684 derivative securities tied to partnership units. Each PIU can convert into one OP Unit, and each OP Unit is redeemable at the holder’s election for cash equal to the fair market value of one share of Omega Healthcare common stock, or, at the issuer’s election, one share of common stock. The award is subject to a three-year cliff vesting on 12/31/2028, requiring continued employment through that date, and the OP Units have no expiration date.
Omega Healthcare Investors Inc. reported that Chief Executive Officer and director C. Taylor Pickett received an award of 57,331 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership on 01/13/2026. Each PIU represents a contingent right to receive one limited partnership unit (an OP Unit) upon vesting and meeting certain tax-related economic requirements.
Each OP Unit is redeemable, at the holder’s election, for cash equal to the fair market value of one share of Omega common stock, or, at Omega’s election, one share of its common stock, and the OP Units have no expiration date. The award is subject to a three-year vesting cliff on 12/31/2028, conditioned on continued employment with specified exceptions, and brings Pickett’s total beneficially owned derivative securities to 569,974 OP Units held directly.
Omega Healthcare Investors' chief financial officer, Robert O. Stephenson, reported an equity-based award of 20,799 Profits Interest Units on a recent Form 4. The award was granted on 01/13/2026 at a price of $0 and increases his beneficial holdings of derivative securities to 231,374 units held directly.
The Profits Interest Units are in OHI Healthcare Properties Limited Partnership, where Omega Healthcare is the general partner. Each PIU can convert into one OP Unit upon vesting and meeting certain tax-related conditions. Each OP Unit is redeemable at the holder’s election for cash equal to the fair market value of one share of Omega Healthcare common stock, or, at the company’s election, one share of common stock. The award is subject to a three-year cliff vesting on 12/31/2028, conditioned on continued employment with limited exceptions.
Omega Healthcare Investors reported that its Chief Financial Officer, Robert O. Stephenson, acquired two awards of Profits Interest Units on January 8, 2026. One transaction covered 115,078 Profits Interest Units at a price of $0 per unit, bringing his total reported derivative holdings related to that award to 167,059 units. A second transaction covered 43,516 Profits Interest Units at a price of $0 per unit, with total holdings for that award rising to 210,575 units.
The filing explains that these Profits Interest Units in OHI Healthcare Properties Limited Partnership have been earned, but not yet vested, based on the company’s Absolute and Relative Total Shareholder Return for the 2023–2025 performance period. According to the certification by the Compensation Committee, 25% of the earned units will vest at the end of each quarter of 2026, subject to continued employment and certain acceleration events. Each unit represents a contingent right to receive one OP Unit in the operating partnership, and OP Units do not expire.
Omega Healthcare Investors reported that its Chief Executive Officer and director, C. Taylor Pickett, received new equity-based awards tied to the company’s operating partnership. On January 8, 2026, he was granted 276,902 Profits Interest Units (PIUs), bringing his directly held PIUs to 407,935.
On the same date, he was also granted an additional 104,708 PIUs, increasing his directly held PIUs to 512,643. Each PIU represents a contingent right to receive one operating partnership unit once vesting and certain tax-related conditions are met, and the underlying OP Units do not expire.
The filing explains that the PIUs were earned, but are not yet vested, based on the company’s Absolute and Relative Total Shareholder Return for the 2023–2025 performance period. A quarter of the earned PIUs will vest at the end of each quarter of 2026, subject to continued employment and possible accelerated vesting upon certain events.
Omega Healthcare Investors reported a Form 4 for Chief Legal Officer Gail D. Makode covering performance-based equity awards in the form of Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership. On January 8, 2026, Makode acquired 59,449 PIUs and 22,480 PIUs at a price of $0 per unit, all held directly. Each PIU represents a contingent right to receive one OP Unit of the partnership upon vesting and meeting specified tax-related economic conditions, and OP Units do not expire.
The PIUs were earned, but not yet vested, based on Absolute and Relative Total Shareholder Return for the 2023–2025 performance period, as certified by the Compensation Committee as of January 8, 2026. Twenty-five percent of the earned PIUs will vest at the end of each quarter of 2026, subject to continued employment and possible accelerated vesting upon certain events.
Omega Healthcare Investors reported an equity award for its Chief Investment Officer, Vikas Gupta, tied to long-term performance. On January 8, 2026, Gupta was granted 59,449 Profits Interest Units (PIUs) and another 22,480 PIUs in OHI Healthcare Properties Limited Partnership, where Omega is the general partner. Each PIU is a contingent right to receive one OP Unit upon vesting and meeting tax-related requirements, and OP Units do not expire.
The first PIU grant was earned based on Absolute Total Shareholder Return for the 2023–2025 performance period, and the second on Relative Total Shareholder Return for the same period, both certified by the Compensation Committee as of January 8, 2026. Twenty-five percent of the PIUs earned for 2023–2025 will vest at the end of each quarter of 2026, subject to continued employment and possible accelerated vesting on certain events.
Omega Healthcare Investors reported an insider equity award for its President, Matthew Paul Gourmand. On January 8, 2026, he was granted 59,449 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership at a price of $0 per unit, increasing his beneficial holdings in this derivative security to 95,482 PIUs. On the same date, he was also granted an additional 22,480 PIUs at $0, bringing his total beneficial ownership to 117,962 PIUs.
The PIUs relate to OP Units in the operating partnership and represent a contingent right to receive one OP Unit per PIU upon vesting and satisfaction of specified tax-related conditions. The awards were earned, but not yet vested, based on the company’s Absolute Total Shareholder Return for 2023–2025 and Relative Total Shareholder Return for 2022–2024, with vesting scheduled quarterly during 2026, subject to continued employment and certain acceleration events.
Omega Healthcare Investors reported an equity compensation grant to its Chief Accounting Officer, Neal Ballew. On January 8, 2026, Ballew was awarded 59,449 Profits Interest Units (PIUs) and a separate grant of 22,480 PIUs in OHI Healthcare Properties Limited Partnership, the operating partnership for the company. Each PIU represents a contingent right to receive one OP Unit, which is a limited partnership interest, once vesting and certain tax-related conditions are met.
The PIUs were earned, but not yet vested, based on Absolute and Relative Total Shareholder Return over the 2023–2025 performance period, as certified by the compensation committee. According to the award terms, 25% of the PIUs earned for this period will vest at the end of each quarter of 2026, subject to continued employment and possible accelerated vesting upon certain events.
Omega Healthcare Investors filed an amended insider trading report for its Chief Executive Officer and director. The filing restates details of a prior transaction in which the executive redeemed 200,000 OP Units in OHI Healthcare Properties Limited Partnership, each tied economically to one share of Omega Healthcare common stock. Each OP Unit was redeemed for cash based on the average closing price over ten trading days, confirmed here as $44.25 per share.
The amendment also notes that 20,000 underlying shares from this redemption were matchable with a purchase of 20,000 Omega Healthcare shares on November 5, 2025 under Section 16(b), and the executive has paid $22,144 to the company as short-swing profit. The company explains this amendment corrects a typographical error in the previously reported average price, while the actual redemption price and profit repayment figures remain the same.
Omega Healthcare Investors' chief financial officer reported an insider share transfer involving common stock of the company. On 12/31/2025, the officer made a gifted transfer of 31,426 shares of common stock at a stated price of $0, reflecting an estate planning move.
According to the filing, the transaction was a gift of shares to a revocable trust established for the benefit of the officer's spouse. Following this transaction, the officer beneficially owned 147,000 shares directly and 31,426 shares indirectly through the trust.
Omega Healthcare Investors chief accounting officer reported routine share activity involving company stock. On 01/01/2026, the officer acquired 173 shares of common stock at $35.89 through the company’s Employee Stock Purchase Plan, then disposed of 12 shares at $44.34 to cover tax withholding tied to that ESPP purchase. After these transactions, the officer directly beneficially owned 4,348 shares of common stock.
The filing also details vesting activity in performance-based and time-based Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership that convert into OP Units, and related redemptions of OP Units into common stock. On 12/31/2025, multiple tranches of PIUs vested into OP Units and OP Units were redeemed for an aggregate of 34,235 shares of common stock at a stated exercise price of $0, resulting in beneficial ownership of 127,839 shares of common stock after the reported derivative transactions.
Omega Healthcare Investors reported insider equity award activity for its President on a Form 4. On 12/31/2025, several tranches of Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership vested into OP Units, and OP Units were converted into common stock at an exercise price of $0 per unit. The derivative table shows vesting and conversions involving 11,627, 12,042 and 15,408 units or shares in multiple entries. The PIUs are performance- and time-based awards tied to Absolute and Relative Total Shareholder Return for the 2022–2024 period and a three-year time-based schedule, all subject to continued employment and potential accelerated vesting under certain circumstances.
Omega Healthcare Investors’ Chief Investment Officer reported several equity award transactions dated 12/31/2025. These involved Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership converting into OP Units, and OP Units converting into common stock at an exercise price of $0.
The filing shows 11,627, 12,042 and 15,408 PIUs vesting into OP Units based on performance and time-based criteria, and corresponding OP Units converting into the same numbers of shares of common stock. The PIUs and OP Units are subject to continued employment and, in some cases, performance based on absolute and relative total shareholder return for the 2022–2024 period, with potential accelerated vesting under certain circumstances.
Omega Healthcare Investors Inc. reported equity award activity for its Chief Legal Officer. On 12/31/2025, various Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership vested and converted into limited partnership units (OP Units), and certain OP Units were exchanged into common stock equivalents, all at a stated price of $0 per unit.
One transaction shows 11,627 PIUs converting into OP Units with 55,798 derivative securities then beneficially owned, with similar activity for blocks of 12,042 and 15,408 PIUs. OP Units can be redeemed for cash equal to the fair market value of one share of Omega Healthcare common stock, or, at the issuer’s election, one share of common stock. The PIUs are tied to performance over the 2022–2024 period and three-year time-based vesting, subject to continued employment and potential accelerated vesting in certain situations.
Omega Healthcare Investors’ chief financial officer reports equity award activity and a small stock disposition. On December 30, 2025, the CFO reported a disposition of 3,850 shares of common stock coded as a transaction type "G" at a stated price of $0, leaving 178,426 shares of common stock beneficially owned directly.
The filing also details the vesting and conversion of Profits Interest Units in OHI Healthcare Properties Limited Partnership into OP Units, and related movements between OP Units and common stock, all at a stated exercise or conversion price of $0. These interests are tied to performance-based and time-based vesting conditions, including measures such as Absolute and Relative Total Shareholder Return for the 2022–2024 period and ongoing employment requirements.
Omega Healthcare Investors insider reporting shows activity by its Chief Executive Officer and director involving operating partnership units and performance-based awards. On December 30, 2025, the reporting person redeemed 200,000 OP Units in OHI Healthcare Properties Limited Partnership, which are exchangeable for cash equal to the average closing price of Omega’s common stock over a 10-day period, noted here as $45.25 per share equivalent. The filing also details multiple awards of Profits Interest Units that can vest into OP Units and, in some cases, be settled in common stock, with several transactions reported at an exercise price of $0.
The report states that a portion of the OP Unit redemption, tied to 20,000 underlying shares, was matchable under Section 16(b) against a prior purchase on November 5, 2025, and the insider paid $22,144.00 to the company as the full profit on that short-swing transaction.
Omega Healthcare Investors (OHI) reported an insider purchase by its Chief Investment Officer. On 11/06/2025, the officer purchased 11,500 shares of common stock at a weighted average price of $42.9668, disclosed as multiple trades within a range of $42.929 to $42.97. Following the transaction, the officer beneficially owns 13,773 shares, held directly.
Omega Healthcare Investors (OHI) reported an insider purchase by its Chief Executive Officer and director. On 11/05/2025, the reporting person bought 20,000 shares of common stock (transaction code P) at a weighted average price of $43.1428, with individual trade prices ranging from $43.05 to $43.25.
Following the transaction, beneficial ownership consists of 20,000 shares held indirectly through a family trust and 4,100 shares held directly.
Omega Healthcare Investors reporting person Robert O. Stephenson, the company's Chief Financial Officer, disclosed vesting of performance-based partnership units on 09/30/2025. Certain Profits Interest Units (PIUs) converted to Operating Partnership (OP) Units: 25,737 PIUs and 26,658 PIUs vested (separately for Absolute and Relative TSR performance), yielding corresponding OP Units and underlying common stock equivalents. After these transactions the filing shows beneficial ownership figures of 570,565 and 597,223 OP Units/common-stock equivalents across the reported items and totals of 160,861 and 134,203 PIU-derived OP Units noted. OP Units are redeemable for cash equal to fair market value or, at the issuer's election, for common stock.
Omega Healthcare Investors insider Form 4: Pickett C. Taylor, listed as Director and Chief Executive Officer, reported vesting conversions on 09/30/2025 that increased his holdings in the company and its operating partnership. Two sets of Profits Interest Units (PIUs) converted into OP Units (60,459 and 62,622 units) with a stated price of $0, increasing the reported OP Unit beneficial ownership levels to 388,506 and 325,884, respectively. Those OP Units also correspond to common stock equivalents: the conversions are shown as underlying Common Stock amounts that raise his reported common-equivalent holdings to 1,072,128 and 1,134,750. The filing notes the 2022–2024 performance-period vesting (25% per quarter) tied to Absolute and Relative Total Shareholder Return and explains OP Units are redeemable for cash equal to fair market value or, at the issuer's election, for shares. The form is signed by Meghan C. Lyons as attorney-in-fact on 10/01/2025.
Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors, Inc. (OHI) reported vesting of performance-based units on 09/30/2025. A total of 23,669 Profits Interest Units (PIUs) converted into an equal number of OP Units through two separate vesting events of 11,627 and 12,042 units. The filing shows the resulting beneficial ownership counts following each conversion: 79,467 and 67,425 OP Units on the profits-interest lines, and reported common-stock equivalents of 152,906 and 164,948 shares on the OP Unit lines. The PIUs vesting resulted from the 2022–2024 performance period: one tranche vested based on Absolute Total Shareholder Return and the other based on Relative Total Shareholder Return, each representing 25% of the PIUs vesting at quarter end and subject to continued employment and certain acceleration conditions.
Omega Healthcare Investors insider Vikas Gupta reported conversion of performance-based units into limited partnership units and underlying common stock equivalents. On 09/30/2025 Mr. Gupta had Profits Interest Units (PIUs) and OP Units vest: 11,627 PIUs converted to 11,627 OP Units and 12,042 PIUs converted to 12,042 OP Units, each with $0 exercise price. Following these transactions he beneficially owned 154,386 common-stock-equivalent OP Units from one tranche and 166,428 from another tranche, for totals shown on the filing. The PIUs vesting represented 25% quarterly vesting tied to the 2022–2024 Absolute and Relative Total Shareholder Return performance periods, subject to continued employment and certain acceleration provisions.
Matthew Paul Gourmand, President of Omega Healthcare Investors, reported transactions dated 09/30/2025 showing vesting and conversion of performance-based units into operating partnership units and common-stock equivalents. Two sets of Profits Interest Units (PIUs) vested into OP Units: 11,627 PIUs (Absolute TSR tranche) and 12,042 PIUs (Relative TSR tranche). Each vested PIU converts to one OP Unit with a $0 stated conversion price, and OP Units are redeemable for cash equal to the then fair market value of one share of common stock or, at the issuer’s election, one share of common stock. Following the reported transactions the filing shows beneficial ownership totals of 87,152 and 75,110 PIUs and common-stock-equivalent OP Unit totals of 140,274 and 152,316 respectively. Vesting was based on 2022–2024 performance periods and is subject to continued employment and acceleration conditions.
Insider transactions by Neal Ballew at Omega Healthcare Investors (OHI) show purchases and vesting activity tied to compensation programs. On 10/01/2025 the reporting person purchased 201 shares under the company ESPP at $31.16 and simultaneously sold 201 shares to cover tax withholding at $42.22, leaving 4,187 shares beneficially owned after the sale. Separately, portions of performance-based Profits Interest Units (PIUs) vested on 09/30/2025, converting to OP Units and increasing direct ownership: 9,248 and 9,579 PIUs vested into corresponding OP Units, raising OP Unit and equivalent common stock holdings as disclosed. Explanations state vesting occurred quarterly in 2025 based on Absolute and Relative TSR for 2022–2024 and OP Units are redeemable for cash or common stock with no expiration.